234 related articles for article (PubMed ID: 17203011)
1. The effect of catecholamine depletion by alpha-methyl-para-tyrosine on measures of cognitive performance and sleep in abstinent MDMA users.
McCann UD; Peterson SC; Ricaurte GA
Neuropsychopharmacology; 2007 Aug; 32(8):1695-706. PubMed ID: 17203011
[TBL] [Abstract][Full Text] [Related]
2. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
Quednow BB; Jessen F; Kuhn KU; Maier W; Daum I; Wagner M
J Psychopharmacol; 2006 May; 20(3):373-84. PubMed ID: 16574711
[TBL] [Abstract][Full Text] [Related]
3. Sleep deprivation differentially impairs cognitive performance in abstinent methylenedioxymethamphetamine ("Ecstasy") users.
McCann UD; Wilson MJ; Sgambati FP; Ricaurte GA
J Neurosci; 2009 Nov; 29(44):14050-6. PubMed ID: 19890014
[TBL] [Abstract][Full Text] [Related]
4. Altered pain responses in abstinent (±)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users.
McCann UD; Edwards RR; Smith MT; Kelley K; Wilson M; Sgambati F; Ricaurte G
Psychopharmacology (Berl); 2011 Oct; 217(4):475-84. PubMed ID: 21603895
[TBL] [Abstract][Full Text] [Related]
5. Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ("Ecstasy").
Quednow BB; Kühn KU; Hoppe C; Westheide J; Maier W; Daum I; Wagner M
Psychopharmacology (Berl); 2007 Jan; 189(4):517-30. PubMed ID: 16425060
[TBL] [Abstract][Full Text] [Related]
6. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
Morgan MJ; McFie L; Fleetwood H; Robinson JA
Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362
[TBL] [Abstract][Full Text] [Related]
7. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
8. Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function.
Curran HV; Verheyden SL
Psychopharmacology (Berl); 2003 Aug; 169(1):91-103. PubMed ID: 12759801
[TBL] [Abstract][Full Text] [Related]
9. Patterns of memory dysfunction in current and 2-year abstinent MDMA users.
Ward J; Hall K; Haslam C
J Clin Exp Neuropsychol; 2006 Apr; 28(3):306-24. PubMed ID: 16618622
[TBL] [Abstract][Full Text] [Related]
10. Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study.
McCann UD; Mertl M; Eligulashvili V; Ricaurte GA
Psychopharmacology (Berl); 1999 Apr; 143(4):417-25. PubMed ID: 10367560
[TBL] [Abstract][Full Text] [Related]
11. Impaired cognitive performance in drug free users of recreational ecstasy (MDMA).
Gouzoulis-Mayfrank E; Daumann J; Tuchtenhagen F; Pelz S; Becker S; Kunert HJ; Fimm B; Sass H
J Neurol Neurosurg Psychiatry; 2000 Jun; 68(6):719-25. PubMed ID: 10811694
[TBL] [Abstract][Full Text] [Related]
12. (+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies.
McCann UD; Eligulashvili V; Ricaurte GA
Neuropsychobiology; 2000; 42(1):11-6. PubMed ID: 10867551
[TBL] [Abstract][Full Text] [Related]
13. Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits.
Parrott AC; Lees A; Garnham NJ; Jones M; Wesnes K
J Psychopharmacol; 1998; 12(1):79-83. PubMed ID: 9584971
[TBL] [Abstract][Full Text] [Related]
14. Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users.
Reneman L; Schilt T; de Win MM; Booij J; Schmand B; van den Brink W; Bakker O
J Psychopharmacol; 2006 May; 20(3):389-99. PubMed ID: 16574713
[TBL] [Abstract][Full Text] [Related]
15. MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users.
Parrott AC
Neurosci Biobehav Rev; 2013 Sep; 37(8):1466-84. PubMed ID: 23660456
[TBL] [Abstract][Full Text] [Related]
16. [3,4-methylenedioxymethamphetamine ('ecstasy'): its long-term emotional and cognitive effects, and serotonin depletion].
Molero-Chamizo A
Rev Neurol; 2005 Jul 16-31; 41(2):108-14. PubMed ID: 16028190
[TBL] [Abstract][Full Text] [Related]
17. Functional Magnetic Resonance Imaging in Abstinent MDMA Users: A Review.
Garg A; Kapoor S; Goel M; Chopra S; Chopra M; Kapoor A; McCann UD; Behera C
Curr Drug Abuse Rev; 2015; 8(1):15-25. PubMed ID: 25731754
[TBL] [Abstract][Full Text] [Related]
18. Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users.
McCann UD; Eligulashvili V; Mertl M; Murphy DL; Ricaurte GA
Psychopharmacology (Berl); 1999 Nov; 147(1):56-65. PubMed ID: 10591869
[TBL] [Abstract][Full Text] [Related]
19. Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on behavioral measures of impulsivity: alone and in combination with alcohol.
Ramaekers JG; Kuypers KP
Neuropsychopharmacology; 2006 May; 31(5):1048-55. PubMed ID: 16160704
[TBL] [Abstract][Full Text] [Related]
20. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
Gouzoulis-Mayfrank E; Thimm B; Rezk M; Hensen G; Daumann J
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):819-27. PubMed ID: 12921915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
